The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

CDDF 11th Spring Conference 2020

Current and Future Challenges of Innovative Oncology Drugs Development

Noordwijk aan Zee, Netherlands – 10-12 February 2020


The Cancer Drug Development Forum (CDDF) Spring conference 2020 is a unique forum that convenes every year and gathers the leaders in the world of innovative cancer therapy development, including medical researchers, pharmaceutical industry representatives, regulatory authority representatives and patient advocacy groups. It is the successor of the former CDDF Alpine Conference and the 11th edition took place from 10 to 12 February 2020, in Noordwijk aan Zee (NL).

This multi-stakeholder, interactive meeting offered plenary lectures with moderated discussions, including case studies and networking opportunities. The programme focused on the latest and future challenges of Innovative oncology drug development with a special emphasis on rational combination therapies, tumor agnostic drug development, cell therapy, and regulatory guidance on oncology drug development.


  • Jaap Verweij (CDDF Board, UK)
  • Stefan Schwoch (Lilly, UK)
  • Irmela Radtke (Roche, CH)
  • Paul Stockman (Astrazeneca, UK)




  • Conference photos are available HERE





Cancer Drug Development Forum asbl
Registered office: c/o BLSI, Clos Chapelle-aux-Champs 30, 1200 Woluwe Saint Lambert, Belgium
Register of legal entities: the French Speaking Enterprise Court in Brussels
Enterprise number: 738.523.752
Tel: +32 2 880 62 70